TrialJournal of virology2017

Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.

Diogo M Magnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.